Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/02/2012WO2012103421A1 Adjuvant nanoemulsions with crystallisation inhibitors
08/02/2012WO2012103411A2 Controlled-release melatonin composition and related methods
08/02/2012WO2012103186A2 Androgen composition for treating an opthalmic condition
08/02/2012WO2012103119A1 Compositions for administering rifalazil and other anti-tuberculosis agents in unit dosage form for oral administration
08/02/2012WO2012103039A1 Surfactant compositions
08/02/2012WO2012103038A2 Nanoparticle compositions, formulations thereof, and uses therefor
08/02/2012WO2012103036A1 Compositions of empty nanoparticles and their use for treating dermatological conditions
08/02/2012WO2012103035A1 Nanoparticle compositions
08/02/2012WO2012103016A2 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
08/02/2012WO2012103015A2 Extended-release beta agonist/steroid transdermal patches and methods for using the same
08/02/2012WO2012102936A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
08/02/2012WO2012102821A1 Low temperature hyperthermia system for therapeutic treatment of invasive agents
08/02/2012WO2012102816A1 System for correlating energy field characteristics with target particle characteristics in a living organism
08/02/2012WO2012102538A2 Dry syrup composition
08/02/2012WO2012102364A1 Composition containing polyunsaturated fatty acid
08/02/2012WO2012102363A1 Drug delivery system and use of same
08/02/2012WO2012102362A1 Pharmaceutical composition containing drug having poor water solubility
08/02/2012WO2012102242A1 Hydrous adhesive patch
08/02/2012WO2012102216A1 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
08/02/2012WO2012102210A1 Gel composition and use thereof
08/02/2012WO2012101657A1 Process for preparation of a herbal extract
08/02/2012WO2012101653A2 Modified release pharmaceutical compositions memantine
08/02/2012WO2012101639A2 Nanoparticles for dermal and systemic delivery of drugs
08/02/2012WO2012101638A2 Nanoparticles for cosmetic applications
08/02/2012WO2012101587A1 Carriers for the local release of hydrophilic prodrugs
08/02/2012WO2012101500A1 Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
08/02/2012WO2012101455A1 Drug delivery systems
08/02/2012WO2012101309A1 Peptide-functionalised nanoliposomes
08/02/2012WO2012101242A1 Novel pharmaceutical suspension for parenteral application
08/02/2012WO2012101218A1 Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
08/02/2012WO2012101181A1 Compositions and methods for cell transplantation
08/02/2012WO2012101167A1 Protection of microbial cells from acidic degradation
08/02/2012WO2012101016A1 Testosterone formulations
08/02/2012WO2012100949A1 Oral dosage forms for modified release comprising tasocitinib
08/02/2012WO2012100948A1 Pharmaceutical compositions comprising tasocitinib
08/02/2012WO2012100754A1 Chinese medicine composition for treating stab wounds, burns, and various traumas
08/02/2012WO2012100590A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012100408A1 Dextrin inclusion complex, preparation method thereof and pharmaceutical formulation comprising said inclusion complex
08/02/2012WO2012100366A1 Liposome and personal care composition comprising thereof
08/02/2012WO2012100295A1 Extended release acetaminophen liquid pharmaceutical compositions
08/02/2012WO2012078528A3 Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
08/02/2012WO2012075451A3 Clonidine and gaba compounds in a biodegradable polymer carrier
08/02/2012WO2012075440A3 Compositions and methods for delivering clonidine to a target tissue site
08/02/2012WO2012071480A3 Lipophilic glucocorticosteroid monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
08/02/2012WO2012068076A3 Pharmaceutical formulations containing soluble drugs
08/02/2012WO2012065060A3 Gas-filled microbubbles and systems for gas delivery
08/02/2012WO2012064300A3 Desloratadine granules
08/02/2012WO2012053014A3 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
08/02/2012WO2012053013A3 Pharmaceutical compositions of anti-acne agents
08/02/2012WO2012053010A3 Method for treatment of acne using pharmaceutical compositions of clindamycin
08/02/2012WO2012053006A3 Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof
08/02/2012WO2012052561A3 Topical dermal delivery device for nitric oxide delivery
08/02/2012WO2012050922A3 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
08/02/2012WO2012047893A3 Use of rifazil and analogues thereof to treat ocular disorders
08/02/2012WO2012042197A3 Low dose pharmaceutical composition comprising zanamivir
08/02/2012WO2012031999A3 Low-dose transdermal patches with high drug release
08/02/2012WO2012027378A3 Particles for drug delivery and other applications
08/02/2012WO2012019990A3 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
08/02/2012WO2012019989A3 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
08/02/2012WO2012019010A3 Antacid formulations and associated methods
08/02/2012WO2012017349A3 Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
08/02/2012WO2012011740A8 Method for preparing microspheres and microspheres produced thereby
08/02/2012WO2011141685A3 Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
08/02/2012WO2011107653A8 Use of levodopa, carbidopa and entacapone for treating parkinson's disease
08/02/2012WO2011100209A3 Magnetically sensitive drug carriers for treatment or targeted delivery
08/02/2012US20120197221 Transepidermal drug delivery system containing rivastigmine
08/02/2012US20120197114 Nanocarriers for imaging and therapy applications
08/02/2012US20120196940 Pharmaceutical formulations
08/02/2012US20120196909 Deferacirox dispersible tablets
08/02/2012US20120196843 Compositions containing topical-active agents and pentyleneglycol
08/02/2012US20120196057 Combination of vitamin d and 25-hydroxyvitamin d 3
08/02/2012US20120195968 Controlled-release melatonin compositions and related methods
08/02/2012US20120195967 Silk-based drug delivery system
08/02/2012US20120195966 Oral dosage form for modified release comprising a jak3 inhibitor
08/02/2012US20120195965 Solid dosage form comprising a fibrate
08/02/2012US20120195964 Phosphate-binding magnesium salts and uses thereof
08/02/2012US20120195963 Highly purified ethyl epa and other epa derivatives
08/02/2012US20120195962 Multiepitope Vaccine for Her2/Neu-Associated Cancers
08/02/2012US20120195961 Use of Spinosyns and Spinosyn Compositions Against Disease Caused By Protozoans, Viral Infections and Cancer
08/02/2012US20120195960 Post-exposure therapy of influenza a infections
08/02/2012US20120195959 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
08/02/2012US20120195958 Implantable devices
08/02/2012US20120195957 Novel nanoparticle formulations for skin delivery
08/02/2012US20120195956 Adhesive skin patch
08/02/2012US20120195955 Sublingual films
08/02/2012US20120195954 Method of Reducing Appetite
08/02/2012US20120195953 Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
08/02/2012US20120195951 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
08/02/2012US20120195947 Protein nanocarriers for topical delivery
08/02/2012US20120195945 Cosmetological and pharmaceutical formulae for the rejuvenation and restoration of skin, including after surgical procedures
08/02/2012US20120195943 Bone delivery device
08/02/2012US20120195942 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
08/02/2012US20120195940 Nanolipidic Particles
08/02/2012US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
08/02/2012US20120195938 Formulations and methods for recovery from dental surgery
08/02/2012US20120195937 Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines
08/02/2012US20120195936 Rna with a combination of unmodified and modified nucleotides for protein expression
08/02/2012US20120195935 Microbubble assisted viral delivery
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 2991